Liothyronine(T3)

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
'''Liothyronine(T3)'''
'''Liothyronine(T3)'''
 +
'''Triiodothyronine''', [[carbon|C<sub>15</sub>]][[hydrogen|H<sub>12</sub>]][[iodine|I<sub>3</sub>]][[nitrogen|N]][[oxygen|O<sub>4</sub>]], also known as '''T<sub>3</sub>''', is a [[thyroid hormone]].
-
'''Pubchem(5920)'''
+
[[Thyroid-stimulating hormone]] (TSH) activates the production of [[thyroxine]] (T<sub>4</sub>) and T<sub>3</sub>. This process is under regulation. In the [[hypothalamus]], T<sub>4</sub> is converted to T<sub>3</sub>. TSH is inhibited mainly by T<sub>3</sub>. The thyroid gland releases greater amounts of T<sub>4</sub> than T<sub>3</sub>, so plasma concentrations of T<sub>4</sub> are 40-fold higher than those of T<sub>3</sub>. Most  of the circulating T<sub>3</sub> is formed peripherally by deiodination of T<sub>4</sub> (85%), a process that involves the removal of iodine from carbon 5 on the outer ring of T<sub>4</sub>. Thus, T<sub>4</sub> acts as prohormone for T<sub>3</sub>.
-
A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
+
This [[thyroid hormone]] is similar to [[thyroxine]] but with one fewer [[iodine]] [[atoms]] per [[molecule]]. In addition, T<sub>3</sub> exhibits greater activity and is produced in smaller quantity.
 +
 
 +
It is the most powerful [[thyroid hormone]], and affects almost every process in the body, including [[body temperature]], [[growth]], and [[heart rate]].
 +
 
 +
== Production of T<sub>3</sub> ==
 +
T<sub>3</sub> is metabolically active hormone that is produced from T<sub>4</sub>. T<sub>4</sub> is deiodinated by two deiodinases to produce the active triiodothyronine:<br />
 +
1. '''Type I''' present within the liver and accounts for 80% of the deiodination of T<sub>4</sub> <br />
 +
2. '''Type II''' present within the pituitary.
 +
 
 +
T<sub>4</sub> is synthesised in the thyroid gland follicular cells as follows.<br />
 +
1. The Na<sup>+</sup>/I<sup>-</sup> symporter transports two sodium ions across the basement membrane of the follicular cells along with an iodine ion. This is secondary active transporter that utilises the concentration gradient of Na<sup>+</sup> to move I<sup>-</sup> against its concentration gradient.<br />
 +
2. I<sup>-</sup> is moved across the apical membranae into the colloid of the follicle.<br />
 +
3. Thyroperoxidase oxidises two I<sup>-</sup> to form I<sub>2</sub>. Iodide is non-reactive and only the more reactive iodine is required for the next step.<br />
 +
4. The thyroperoxidase iodinates the tyrosyl residues of the thyroglobulin within the colloid. The thyroglobulin was synthesis in the ER of the follicular cell and secreted into the colloid.<br />
 +
5. Thyroid stimulating hormone (TSH) released from the pituitary gland binds the TSH receptor ( a G<sub>s</sub> protein coupled receptor) on the basolateral membrane of the cell and stimulates the endocytosis of the colloid.<br />
 +
6. The endosytosed vesicles fuse with the lysosomes of the follicular cell. The lysosomal enzymes cleave the T<sub>4</sub> from the iodinated thyroglobulin.<br />
 +
7. These vesicles are then exocytosed releasing the thyroid hormones.
 +
 
 +
In the follicular lumen, [[tyrosine]] residues become iodinated. This reaction requires hydrogen peroxide. Iodine bonds carbon 3 or carbon 5 of tyrosine residues of thyroglobulin in a process called organification of iodine. The iodination of specific tyrosines yields monoiodotyrosine (MIT) and diiodotyrosine (DIT). One MIT and one DIT are enzymatically coupled to form T<sub>3</sub>. The enzyme is thyroid [[peroxidase]].
 +
 
 +
[[Image:Iodothyronine deiodinase.png|thumb|400px|left|Synthesis]]<br style="clear:left;"/>
 +
 
 +
== Transport of Triiodothyronine ==
 +
The T<sub>3</sub> (and T<sub>4</sub>) bind to nuclear receptors, thyroid receptors. However, T<sub>3</sub> (and T<sub>4</sub>) are not very lipophilic and as a result, are unable to pass through the phospholipid bilayers. They therefore have specific transport proteins on the cell membranes of the effector organs which allow the T<sub>3</sub> and T<sub>4</sub> to pass into the cells. The thyroid receptors bind to response elements in gene promoters and thus enabling them to activate or inhibit transcription. The sensitivity of a tissue to T<sub>3</sub> is modulated through the thyroid receptors.
 +
 
 +
== Mechanism of Action ==
 +
T<sub>3</sub> and T<sub>4</sub> are carried in the blood bound to plasma proteins. This has the effect of increasing the [[half life]] of the hormone and decreasing the rate at which it is taken up by peripheral tissues. There are three main proteins that the two hormones are bound to. Thyronine binding globulin (TBG) is a gylcoprotein that has a higher affinity for T<sub>4</sub> than for T<sub>3</sub>. The second plasma protein to which the hormone bind is transthyretin (which has a higher affinity for T<sub>3</sub> than for T<sub>4</sub>. Both hormones bind with a low affinity to [[albumin]], but due to the large availability of albumin it has a high capacity.
 +
 
 +
== Effects of T<sub>3</sub> ==
 +
T<sub>3</sub> increases the [[basal metabolic rate]] and thus increases the body's oxygen and energy consumption. The basal metabolic rate is the minimal caloric requirement  needed to sustain life in a resting individual. T<sub>3</sub> acts on the majority of tissues within the body, with a few exceptions including the brain, spleen and testis. It increases the production of the Na<sup>+</sup>/K<sup>+</sup> -ATPase and in general increases the turnover of different endogenous macromolecules by increasing their synthesis and degradation.
 +
 
 +
'''Protein'''<br />T<sub>3</sub> stimulates the production of [[RNA Polymerase]] I and II and therefore increases the rate of protein synthesis. It also increases the rate of protein degradation and in excess the rate of protein degradation exceeds the rate of protein synthesis. In such situations the body may go into negative ion balance.
 +
 
 +
'''Glucose'''<br /> T<sub>3</sub> potentiates the effects of the β-adrenergic receptors on the metabolism of glucose.  It therefore increases the rate of glycogen breakdown and glucose synthesis in [[gluconeogenesis]].  It also potentiates the effects of [[insulin]], which have opposing effects.
 +
 
 +
'''Lipids'''<br />T<sub>3</sub> stimulates the breakdown of cholesterol and increases the number of LDL receptors, therefore increasing the rate of lipolysis.
 +
 
 +
T<sub>3</sub> also affects the cardiovascular system. It increases the cardiac output by increasing the heart rate and force of contraction.  This results in increased [[systolic blood pressure]] and decreased [[diastolic blood pressure]]. The latter two effects act to produce the typical bounding pulse seen in hyperthyroidism.
 +
 
 +
T<sub>3</sub> also has profound effect upon the developing embryo and infants. It affects the lungs and influences the postnatal growth of the central nervous system. It stimulates the production of [[myelin]], [[neurotransmitters]] and axon growth. It is also important in the linear growth of bones.
 +
 
 +
'''Pubchem(5920)'''
'''KEGG Pathway(C02465)'''
'''KEGG Pathway(C02465)'''
Line 13: Line 55:
More active than T4
More active than T4
{| border="1;width:100%; height:200px;style=text-align:center"
{| border="1;width:100%; height:200px;style=text-align:center"
-
|+'''Table I:'''
+
|+''List of PDB file having T3 as Ligands'''
|-
|-
! style="background:brown; color:white" |MMDB ID
! style="background:brown; color:white" |MMDB ID
Line 53: Line 95:
|}
|}
{| border="1;width:100%; height:200px;style=text-align:center"
{| border="1;width:100%; height:200px;style=text-align:center"
-
|+'''Table I:'''
+
|+'''Physiochemical Properties'''
|-
|-
! style="background:brown; color:white" |Physical Property
! style="background:brown; color:white" |Physical Property
Line 99: Line 141:
|}
|}
{| border="1;width:100%; height:200px;style=text-align:center"
{| border="1;width:100%; height:200px;style=text-align:center"
-
|+'''Table I:'''
+
|+'''Toxicity'''
|-
|-
! style="background:brown; color:white" |Organism  
! style="background:brown; color:white" |Organism  
Line 115: Line 157:
|-
|-
|}
|}
-
Reference1
+
==Reference==
 +
Cytosporone B is an agonist for nuclear orphan receptor Nur77
 +
Yanyan Zhan1,3, Xiping Du1,3, Hangzi Chen1, Jingjing Liu1, Bixing Zhao1, Danhong Huang1, Guideng Li1, Qingyan Xu1, Mingqing Zhang1, Bart C Weimer2, Dong Chen2, Zhe Cheng1, Lianru Zhang1, Qinxi Li1, Shaowei Li1, Zhonghui Zheng1, Siyang Song1, Yaojian Huang1, Zhiyun Ye1, Wenjin Su1, Sheng-Cai Lin1, Yuemao Shen1 & Qiao Wu1
Nature Chemical Biology 4, 548 - 556 (2008)
Nature Chemical Biology 4, 548 - 556 (2008)
Published online: 10 August 2008 | doi:10.1038/nchembio.106
Published online: 10 August 2008 | doi:10.1038/nchembio.106
-
 
-
Cytosporone B is an agonist for nuclear orphan receptor Nur77
 
-
 
-
Yanyan Zhan1,3, Xiping Du1,3, Hangzi Chen1, Jingjing Liu1, Bixing Zhao1, Danhong Huang1, Guideng Li1, Qingyan Xu1, Mingqing Zhang1, Bart C Weimer2, Dong Chen2, Zhe Cheng1, Lianru Zhang1, Qinxi Li1, Shaowei Li1, Zhonghui Zheng1, Siyang Song1, Yaojian Huang1, Zhiyun Ye1, Wenjin Su1, Sheng-Cai Lin1, Yuemao Shen1 & Qiao Wu1
 
-
 
-
Abstract
 
-
 
-
Nuclear orphan receptor Nur77 has important roles in many biological processes. However, a physiological ligand for Nur77 has not been identified. Here, we report that the octaketide cytosporone B (Csn-B) is a naturally occurring agonist for Nur77. Csn-B specifically binds to the ligand-binding domain of Nur77 and stimulates Nur77-dependent transactivational activity towards target genes including Nr4a1 (Nur77) itself, which contains multiple consensus response elements allowing positive autoregulation in a Csn-B–dependent manner. Csn-B also elevates blood glucose levels in fasting C57 mice, an effect that is accompanied by induction of multiple genes involved in gluconeogenesis. These biological effects were not observed in Nur77-null (Nr4a1-/-) mice, which indicates that Csn-B regulates gluconeogenesis through Nur77. Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release. Thus, Csn-B may represent a promising therapeutic drug for cancers and hypoglycemia, and it may also be useful as a reagent to increase understanding of Nur77 biological function.
 

Revision as of 10:10, 24 October 2008

Liothyronine(T3) Triiodothyronine, C15H12I3NO4, also known as T3, is a thyroid hormone.

Thyroid-stimulating hormone (TSH) activates the production of thyroxine (T4) and T3. This process is under regulation. In the hypothalamus, T4 is converted to T3. TSH is inhibited mainly by T3. The thyroid gland releases greater amounts of T4 than T3, so plasma concentrations of T4 are 40-fold higher than those of T3. Most of the circulating T3 is formed peripherally by deiodination of T4 (85%), a process that involves the removal of iodine from carbon 5 on the outer ring of T4. Thus, T4 acts as prohormone for T3.

This thyroid hormone is similar to thyroxine but with one fewer iodine atoms per molecule. In addition, T3 exhibits greater activity and is produced in smaller quantity.

It is the most powerful thyroid hormone, and affects almost every process in the body, including body temperature, growth, and heart rate.

Contents

Production of T3

T3 is metabolically active hormone that is produced from T4. T4 is deiodinated by two deiodinases to produce the active triiodothyronine:
1. Type I present within the liver and accounts for 80% of the deiodination of T4
2. Type II present within the pituitary.

T4 is synthesised in the thyroid gland follicular cells as follows.
1. The Na+/I- symporter transports two sodium ions across the basement membrane of the follicular cells along with an iodine ion. This is secondary active transporter that utilises the concentration gradient of Na+ to move I- against its concentration gradient.
2. I- is moved across the apical membranae into the colloid of the follicle.
3. Thyroperoxidase oxidises two I- to form I2. Iodide is non-reactive and only the more reactive iodine is required for the next step.
4. The thyroperoxidase iodinates the tyrosyl residues of the thyroglobulin within the colloid. The thyroglobulin was synthesis in the ER of the follicular cell and secreted into the colloid.
5. Thyroid stimulating hormone (TSH) released from the pituitary gland binds the TSH receptor ( a Gs protein coupled receptor) on the basolateral membrane of the cell and stimulates the endocytosis of the colloid.
6. The endosytosed vesicles fuse with the lysosomes of the follicular cell. The lysosomal enzymes cleave the T4 from the iodinated thyroglobulin.
7. These vesicles are then exocytosed releasing the thyroid hormones.

In the follicular lumen, tyrosine residues become iodinated. This reaction requires hydrogen peroxide. Iodine bonds carbon 3 or carbon 5 of tyrosine residues of thyroglobulin in a process called organification of iodine. The iodination of specific tyrosines yields monoiodotyrosine (MIT) and diiodotyrosine (DIT). One MIT and one DIT are enzymatically coupled to form T3. The enzyme is thyroid peroxidase.


Transport of Triiodothyronine

The T3 (and T4) bind to nuclear receptors, thyroid receptors. However, T3 (and T4) are not very lipophilic and as a result, are unable to pass through the phospholipid bilayers. They therefore have specific transport proteins on the cell membranes of the effector organs which allow the T3 and T4 to pass into the cells. The thyroid receptors bind to response elements in gene promoters and thus enabling them to activate or inhibit transcription. The sensitivity of a tissue to T3 is modulated through the thyroid receptors.

Mechanism of Action

T3 and T4 are carried in the blood bound to plasma proteins. This has the effect of increasing the half life of the hormone and decreasing the rate at which it is taken up by peripheral tissues. There are three main proteins that the two hormones are bound to. Thyronine binding globulin (TBG) is a gylcoprotein that has a higher affinity for T4 than for T3. The second plasma protein to which the hormone bind is transthyretin (which has a higher affinity for T3 than for T4. Both hormones bind with a low affinity to albumin, but due to the large availability of albumin it has a high capacity.

Effects of T3

T3 increases the basal metabolic rate and thus increases the body's oxygen and energy consumption. The basal metabolic rate is the minimal caloric requirement needed to sustain life in a resting individual. T3 acts on the majority of tissues within the body, with a few exceptions including the brain, spleen and testis. It increases the production of the Na+/K+ -ATPase and in general increases the turnover of different endogenous macromolecules by increasing their synthesis and degradation.

Protein
T3 stimulates the production of RNA Polymerase I and II and therefore increases the rate of protein synthesis. It also increases the rate of protein degradation and in excess the rate of protein degradation exceeds the rate of protein synthesis. In such situations the body may go into negative ion balance.

Glucose
T3 potentiates the effects of the β-adrenergic receptors on the metabolism of glucose. It therefore increases the rate of glycogen breakdown and glucose synthesis in gluconeogenesis. It also potentiates the effects of insulin, which have opposing effects.

Lipids
T3 stimulates the breakdown of cholesterol and increases the number of LDL receptors, therefore increasing the rate of lipolysis.

T3 also affects the cardiovascular system. It increases the cardiac output by increasing the heart rate and force of contraction. This results in increased systolic blood pressure and decreased diastolic blood pressure. The latter two effects act to produce the typical bounding pulse seen in hyperthyroidism.

T3 also has profound effect upon the developing embryo and infants. It affects the lungs and influences the postnatal growth of the central nervous system. It stimulates the production of myelin, neurotransmitters and axon growth. It is also important in the linear growth of bones.

Pubchem(5920)

KEGG Pathway(C02465)

  • Tyrosine metabolism
  • Neuroactive ligand-receptor interaction

Autoimmune thyroid disease

Comment Thyroid hormone More active than T4

List of PDB file having T3 as Ligands'
MMDB ID PDB ID Reference
10776 1BSX Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KRStructure and specificity of nuclear receptor-coactivator interactionsGenes Dev. v12, p.3343-3356
28583 1SN5 Eneqvist T, Lundberg E, Karlsson A, Huang S, Santos CR, Power DM, Sauer-Eriksson AEHigh resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxineJ. Biol. Chem. v279, p.26411-26416
31718 1XZX Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JDThyroxine-thyroid hormone receptor interactionsJ. Biol. Chem. v279, p.55801-55808
40533 2H6W Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Ne, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov IStructural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor functionJ. Mol. Biol. v360, p.586-598
40534 2H77 Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Ne, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov IStructural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor functionJ. Mol. Biol. v360, p.586-598
40535 PDB ID: 2H79 Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Ne, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov IStructural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor functionJ. Mol. Biol. v360, p.586-598
59297 2PIV Estebanez-Perpina E, Arnold LA, Nguyen P, Rodrigues ED, Mar E, Bateman R, Pallai P, Shokat KM, Baxter JD, Guy RK, Webb P, Fletterick RJA surface on the androgen receptor that allosterically regulates coactivator bindingProc. Natl. Acad. Sci. U. S. A. v104, p.16074-16079
59298 2PIW Estebanez-Perpina E, Arnold LA, Nguyen P, Rodrigues ED, Mar E, Bateman R, Pallai P, Shokat KM, Baxter JD, Guy RK, Webb P, Fletterick RJA surface on the androgen receptor that allosterically regulates coactivator bindingProc. Natl. Acad. Sci. U. S. A. v104, p.16074-16079
Physiochemical Properties
Physical Property Value Units Temp (deg C) Source
Melting Point 236.5 dec deg C EXP
log P (octanol-water) 2.960 (none) EST
Water Solubility 3.96 mg/L 37 EXP
Vapor Pressure 3.90E-16 mm Hg 25 EST
Henry's Law Constant 3.41E-18 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 4.82E-11 cm3/molecule-sec 25 EST
Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
rat LDLo oral 7500mg/kg (7500mg/kg) Roczniki Panstwowego Zakladu Higieny. Vol. 32, Pg. 197, 1981.

Reference

Cytosporone B is an agonist for nuclear orphan receptor Nur77 Yanyan Zhan1,3, Xiping Du1,3, Hangzi Chen1, Jingjing Liu1, Bixing Zhao1, Danhong Huang1, Guideng Li1, Qingyan Xu1, Mingqing Zhang1, Bart C Weimer2, Dong Chen2, Zhe Cheng1, Lianru Zhang1, Qinxi Li1, Shaowei Li1, Zhonghui Zheng1, Siyang Song1, Yaojian Huang1, Zhiyun Ye1, Wenjin Su1, Sheng-Cai Lin1, Yuemao Shen1 & Qiao Wu1 Nature Chemical Biology 4, 548 - 556 (2008) Published online: 10 August 2008 | doi:10.1038/nchembio.106